Need for inclusion of high-risk populations and standardisation of immunogenicity outcomes in adult pneumococcal vaccine trials.
Saved in:
| Title: | Need for inclusion of high-risk populations and standardisation of immunogenicity outcomes in adult pneumococcal vaccine trials. |
|---|---|
| Authors: | Harboe ZB; Department of Pulmonary and Infectious Diseases, Copenhagen University Hospital, Nordsjælland, Hillerød 3400, Denmark; Department of Bacteria, Parasites, and Fungi, Statens Serum Institute, Copenhagen, Denmark; Department of Clinical Medicine, Faculty of Health and Medical Science, University of Copenhagen, Copenhagen, Denmark; European Society of Microbiology and Infectious Diseases (ESCMID) Vaccine Study Group (EVASG), Basel, Switzerland. Electronic address: zitta.barrella.harboe@regionh.dk., Cordero E; Department of Medicine, School of Medicine, University of Seville, Seville, Spain; Clinical Unit of Infectious Diseases and Microbiology, Virgen del Rocío University Hospital, Seville, Spain; Institute of Biomedicine of Seville (IBiS), CIBER in Infectious Diseases, Seville, Spain; European Society of Microbiology and Infectious Diseases (ESCMID) Study Group for Infections in Compromised Hosts (ESGICH), Basel, Switzerland., Moran C; European Society of Microbiology and Infectious Diseases (ESCMID) Study Group for Infections in Compromised Hosts (ESGICH), Basel, Switzerland; Department of Infectious Diseases, Prince of Wales Hospital, Sydney, NSW, Australia., Kuijpers L; European Society of Microbiology and Infectious Diseases (ESCMID) Vaccine Study Group (EVASG), Basel, Switzerland; Leiden University Center for Infectious Diseases (LU-CID), Leiden University Medical Center, Leiden, Netherlands., Epaulard O; European Society of Microbiology and Infectious Diseases (ESCMID) Vaccine Study Group (EVASG), Basel, Switzerland; Infectious Diseases, Centre Hospitalier Universitaire Grenoble Alpes, Grenoble, France; Groupe de Recherche en Infectiologie Clinique, CIC, 1406, Inserm-CHUGA-UGA, Grenoble, France., Vollaard A; European Society of Microbiology and Infectious Diseases (ESCMID) Study Group for Infections in Compromised Hosts (ESGICH), Basel, Switzerland; Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, Netherlands. |
| Source: | The Lancet. Infectious diseases [Lancet Infect Dis] 2025 Jul; Vol. 25 (7), pp. e378-e379. Date of Electronic Publication: 2025 May 09. |
| Publication Type: | Letter |
| Journal Info: | Publisher: Elsevier Science Country of Publication: United States NLM ID: 101130150 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1474-4457 (Electronic) Linking ISSN: 14733099 NLM ISO Abbreviation: Lancet Infect Dis Subsets: MEDLINE; In Process |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
